AP2007003929A0 - A purified arabinogalactan-protein (agp) composition - Google Patents

A purified arabinogalactan-protein (agp) composition

Info

Publication number
AP2007003929A0
AP2007003929A0 AP2007003929A AP2007003929A AP2007003929A0 AP 2007003929 A0 AP2007003929 A0 AP 2007003929A0 AP 2007003929 A AP2007003929 A AP 2007003929A AP 2007003929 A AP2007003929 A AP 2007003929A AP 2007003929 A0 AP2007003929 A0 AP 2007003929A0
Authority
AP
ARIPO
Prior art keywords
agp
protein
composition
purified arabinogalactan
arabinogalactan
Prior art date
Application number
AP2007003929A
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Vandita Srivastava
Sameer Walunj
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of AP2007003929A0 publication Critical patent/AP2007003929A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
AP2007003929A 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition AP2007003929A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
PCT/IN2005/000132 WO2006025068A1 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Publications (1)

Publication Number Publication Date
AP2007003929A0 true AP2007003929A0 (en) 2007-02-28

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003929A AP2007003929A0 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Country Status (19)

Country Link
US (4) US7601368B2 (de)
EP (1) EP1789439B1 (de)
JP (1) JP2008511613A (de)
KR (1) KR20070059062A (de)
CN (1) CN101044161A (de)
AP (1) AP2007003929A0 (de)
AT (1) ATE452142T1 (de)
AU (1) AU2005278780A1 (de)
BR (1) BRPI0514347A (de)
CA (1) CA2577134A1 (de)
DE (1) DE602005018375D1 (de)
EA (1) EA012208B1 (de)
IL (1) IL181230A0 (de)
MX (1) MX2007002428A (de)
NO (1) NO20071120L (de)
TN (1) TNSN07079A1 (de)
UA (1) UA86986C2 (de)
WO (1) WO2006025068A1 (de)
ZA (1) ZA200701311B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
EP2566485B1 (de) 2010-05-05 2017-04-12 Comvita New Zealand Limited Immunstimulationszusammensetzungen und verwendungsverfahren dafür
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
US11179407B2 (en) 2015-12-01 2021-11-23 Forschungszentrum Borstel Leibniz-Zentrum Für Medizin Und Biowissenshaften Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
EP3176175B1 (de) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Verfahren zur synthetischen herstellung von arabinogalactanverbindungen, die abgeleitet sind von pflanzen und verwendung der verbindungen zur prophylaxe von allergischen reaktionen
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液
EP3415586B1 (de) 2016-02-12 2022-11-30 Laimu Corporation Wundbehandlungsmittel und verfahren zur herstellung davon
KR20260092568A (ko) * 2024-12-11 2026-06-19 대한민국(질병관리청 국립보건연구원장) 신규한 일본뇌염 재조합 항원 단백질 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
EP1200482A1 (de) 1999-06-30 2002-05-02 Pharmagenesis, Inc. Hämatopoetische arabinogalaktan-zusammensetzung
US20030194456A1 (en) * 2002-01-10 2003-10-16 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Also Published As

Publication number Publication date
ATE452142T1 (de) 2010-01-15
KR20070059062A (ko) 2007-06-11
CN101044161A (zh) 2007-09-26
EA200700532A1 (ru) 2007-08-31
CA2577134A1 (en) 2006-03-09
EP1789439B1 (de) 2009-12-16
IL181230A0 (en) 2007-07-04
EA012208B1 (ru) 2009-08-28
WO2006025068A8 (en) 2006-04-20
US20090264341A1 (en) 2009-10-22
BRPI0514347A (pt) 2008-06-10
US7601368B2 (en) 2009-10-13
ZA200701311B (en) 2009-08-26
NO20071120L (no) 2007-05-14
MX2007002428A (es) 2007-05-11
US20060045930A1 (en) 2006-03-02
TNSN07079A1 (en) 2008-06-02
WO2006025068A1 (en) 2006-03-09
JP2008511613A (ja) 2008-04-17
US20090270330A1 (en) 2009-10-29
AU2005278780A1 (en) 2006-03-09
EP1789439A1 (de) 2007-05-30
UA86986C2 (ru) 2009-06-10
US20100330650A1 (en) 2010-12-30
DE602005018375D1 (de) 2010-01-28

Similar Documents

Publication Publication Date Title
ZA200701311B (en) A purified arabinogalactan-protein (AGP) composition
EP1749859A4 (de) Härtbare zusammensetzung
IL229521A0 (en) A new preparation
IL185901A0 (en) Novel composition
EP1816168A4 (de) Härtbare zusammensetzung
PL1913075T3 (pl) Mieszanki kauczukowe zawierające ulepszone środki klejące
EP1666536A4 (de) Härtbare zusammensetzung
EP1754754A4 (de) Härtbare zusammensetzung
EP1731549A4 (de) Härtbare zusammensetzung
EP1715002A4 (de) Härtbare zusammensetzung
TWI340128B (en) A glass composition
EP1731573A4 (de) Härtbare zusammensetzung
GB0502479D0 (en) Novel compositions
IL185516A0 (en) A composition
GB0427403D0 (en) Novel compounds I
GB0502475D0 (en) Novel compositions
GB0408083D0 (en) Novel compounds
EP1810995A4 (de) Härtbare zusammensetzung
EP1810996A4 (de) Härtbare zusammensetzung
EP1614717A4 (de) Härtbare zusammensetzung
GB0525321D0 (en) Novel compositions
GB0409898D0 (en) A composition
GB0525592D0 (en) A composition
GB0418296D0 (en) Compositions for bioremediation
HK1102130A (en) A purified arabinogalactan-protein (agp) composition